Health Biotchnology Financial Statements From 2010 to 2024

SHPCX Fund  USD 13.90  0.03  0.22%   
Health Biotchnology financial statements provide useful quarterly and yearly information to potential Health Biotchnology Portfolio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Health Biotchnology financial statements helps investors assess Health Biotchnology's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Health Biotchnology's valuation are summarized below:
Health Biotchnology Portfolio does not presently have any fundamental trends for analysis.
Check Health Biotchnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Health Biotchnology's main balance sheet or income statement drivers, such as , as well as many indicators such as . HEALTH financial statements analysis is a perfect complement when working with Health Biotchnology Valuation or Volatility modules.
  
This module can also supplement various Health Biotchnology Technical models . Check out the analysis of Health Biotchnology Correlation against competitors.

Health Biotchnology Portfolio Mutual Fund Price To Earning Analysis

Health Biotchnology's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Health Biotchnology Price To Earning

    
  18.07 X  
Most of Health Biotchnology's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Health Biotchnology Portfolio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, Health Biotchnology Portfolio has a Price To Earning of 18.07 times. This is much higher than that of the Saratoga family and significantly higher than that of the Health category. The price to earning for all United States funds is notably lower than that of the firm.

Health Biotchnology Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Health Biotchnology's current stock value. Our valuation model uses many indicators to compare Health Biotchnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Health Biotchnology competition to find correlations between indicators driving Health Biotchnology's intrinsic value. More Info.
Health Biotchnology Portfolio is rated top fund in price to earning among similar funds. It also is rated top fund in price to book among similar funds fabricating about  0.15  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Health Biotchnology Portfolio is roughly  6.84 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Health Biotchnology's earnings, one of the primary drivers of an investment's value.

About Health Biotchnology Financial Statements

Health Biotchnology investors use historical fundamental indicators, such as Health Biotchnology's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Health Biotchnology. Please read more on our technical analysis and fundamental analysis pages.
The fund will normally invest at least 80 percent of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value . Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in HEALTH Mutual Fund

Health Biotchnology financial ratios help investors to determine whether HEALTH Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HEALTH with respect to the benefits of owning Health Biotchnology security.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stocks Directory
Find actively traded stocks across global markets